Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_37_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
15.09.2026
Размер:
17 Мб
Скачать
☆
TABLE
Suspensory
e
nerves
https://t.me/medicina_free
12.13
Midazolam (Versed)
CHAPTER 12 Pain and Pain Relief
ANALGESICS, SEDATIVES, AND REVERSAL AGENTS FOR THE NEONATE—CONT’D
NONBARBITURATES
0.05–0.15 mg/kg/dose IV (give over ≥5 min) q 2–4 hr PRN Continuous IV infusion: <32 wk: 0.03 mg/kg/hr or 0.5 mcg/kg/min >32 wk: 0.06 mg/kg/hr or 1 mcg/kg/min PO: 0.25 mg/kg/dose of oral syrup Onset: IV—1–2 min; PO—15–30 min Duration: 1 hr after single IV dose For procedural sedation: Give 0.05 mg/kg IV and repeat ×1 PRN for procedure
Same as for lorazepam; continuous IV infusion enables precise titration until sedative effect is obtained; calms agitated infant on ventilator. Rapid bolus delivery and/ or use with fentanyl is associated with (1) myoclonus— rhythmic twitching of all extremities that ceases with discontinuation of drug and does not return, and (2) respiratory depression and hypotension—caution use in hypotensive and hypovolemic neonates. A systematic review shows (1) increased incidence of adverse neurologic outcomes (e.g., grade 3–4 IVH; PVL), altered CBF; (2) longer duration of NICU stay with mid­azolam use; and (3) conclusion that there is insufficient evidence to support IV midazolam use as a sedative for neonates in the NICU.
295
infants who received midazolam in the NICU found decreased hippocampal volume (and associated lower cognitive scores) and increased mean diffusivity.
309
212,265
Recent study of very preterm
127
REVERSAL AGENTS
Naloxone (Narcan) 0.1 mg/kg Reverses effects of opioids (both side effects
and analgesia).
Flumazenil (Mazicon) 10 mcg/kg 10 mcg/kg Reverses effects of benzodiazepines (e.g.,
midazolam, diazepam, lorazepam).
*Not yet approved by the Food and Drug Administration for use in the United States. CBF, Cerebral blood flow; CNS, central nervous system; EEG, electroencephalography; ELBW, extremely low-birth-weight; EMLA, eutectic mixture of lidocaine and prilocaine; ETT, endo­tracheal tube; G6PD, glucose-6-phosphate dehydrogenase; GI, gastrointestinal; IM, intramuscular; IV, intravenous; IVH, intraventricular hemorrhage; NEC, necrotizing enterocolitis; NICU, neonatal intensive care unit; PICC, percutaneous insertion of central catheter; PO, per os; PR, per rectum; PRN, as needed; PVL, periventricular leukomalacia; ROP, retinopathy of prematurity; sub-Q, subcutaneous; VLBW, very-low-birth-weight.
Eutectic Mixture of Local Anesthetic and Infiltration. EMLA is
Buck’s
fascia
Deep dorsal vein
Deep penil nerves
Corpora cavernosa
Corpus
spongiosum
Dorsal penile
ligament
FIGURE 12.7 Anatomic landmarks for placement of a dorsal penile nerve
block. (From McClain B, Anand KS. Neonatal pain management. In: Deshpande J, Tobias J, eds. The Pediatric Pain Handbook. St Louis, MO: Mosby; 1996.)
a local anesthetic cream that anesthetizes the skin and has been used for a variety of procedures (e.g., lum­bar puncture, venipuncture, immunizations).
205,234,416
A study of EMLA, applied 60 to 90 minutes before lumbar puncture, showed a significant decrease in pain response during needle insertion and withdrawal but not during positioning/handling of the newborn.
EMLA has been used for analgesia with circum­cisions in newborns and has been shown to be efficacious.
416
However, its analgesic properties
are not as effective as those of dorsal penile blocks in relieving postoperative circumcision pain.*
228
UNIT TWO Support of the Neonate310
https://t.me/medicina_free
A meta-analysis of the efficacy of EMLA for a variety of procedures in neonates found that EMLA diminishes pain during circumcision, venipuncture, arterial puncture, and placement of a peripheral/ central IV line.
389,416
For maximum effective-
ness, EMLA should be applied and left on for at least 1 to 2 hours before starting an invasive procedure. Unfortunately, EMLA does not appear
to alleviate pain resulting from heel sticks.
142,389,416
Infiltration of local anesthetic can help decrease pain for procedures such as placement of percuta-
neous central lines, removal of Broviac catheters, and circumcision. Methemoglobinemia does not appear to be a problem when single daily doses of
0.5 g EMLA are left in place for 60 minutes,
389
but
studies are ongoing to address this issue.
Amethocaine gel (lysosome-encapsulated tetra-
caine) is a topical local anesthetic preparation that provides more effective superficial analgesia than EMLA in adults. Amethocaine has demonstrated sim­ilar efficacy to EMLA when appropriate application times are used and has a more rapid onset and longer duration of action than EMLA.
301
Studies have doc-
umented its effectiveness in neonates as follows:
• It relieves pain during venipuncture,
insertion, and injections of vitamin K.
• It does not relieve pain from heel sticks
213,260
357
315
IV
or peripherally inserted central catheter (PICC) insertion, unless combined with morphine use.
• It relieves circumcision pain.
416
388
• It does not cause methemoglobinemia.
• It is effective within 30 to 40 minutes of application. A recent Cochrane review recommends more
research into the safety and efficacy of topical anes­thetics, especially in the very preterm neonate and for multiple applications.
OTHER MEDICATIONS
140
Acetaminophen and nonsteroidal antiinflamma­tory drugs (NSAIDs) can be helpful in provid­ing analgesia for mild to moderate pain (see
Table 12.13). These medications are more effective
when administered on a regular schedule, aug­ment the effects of opioids, and may be delayed in effect because of the rate of gastric emptying.
36,405
Acetaminophen given 2 hours before circumci­sion does not reduce pain during the procedure but is effective in postoperative pain relief; repeated doses every 4 to 6 hours for the first 24 hours after circumcision are recommended.
The analgesic effects of IV NSAIDs have not been
studied in preterm infants, and the adverse effects of prolonged NSAID use may lead to renal, circulatory, hepatic, gastrointestinal, and hematologic complica-
25,31
tions.
Ketorolac in a single dose has been studied in infants as young as 2 months of age and found to be safe and effective at relieving pain.
90,264
Although
use of acetaminophen as a prophylactic for febrile response to immunizations is effective, there is a significantly lower antibody response to vaccine antigen when acetaminophen is used.
329
Sedatives can help decrease agitation and improve
comfort but do not by themselves provide anal-
gesia. Use of developmental care significantly reduces the need of VLBW infants for sedative
411
drugs.
Sedatives are appropriate to induce sleep for diagnostic procedures (e.g., MRI, computed tomography [CT]), to calm chronically irritable infants whose physiologic stability or ventilatory sta­tus is compromised by agitation, and for pain-related agitation.
27,411
Sedatives have potential toxicities, effect behavioral changes, and affect consciousness, which deprive neonates of their ability to commu­nicate and interact with their parents, caregivers, and the environment.
412
Furthermore, the short-term and long-term effects of frequent or continuous use of sedatives on the developing brain are unknown.
Comfort/Nonpharmacologic Measures
Comfort measures alone do not relieve pain; however, their use reduces agitation, which indirectly reduces pain by promoting behavioral organization, relaxation, general comfort, and sleep.13 Although comfort measures may pre­vent the intensification of pain (e.g., guarding an abdominal incision by positioning is less painful than four-point restraint), they may not relieve moderate to severe pain. Comfort mea­sures are helpful but inadequate by themselves, considering the intensity of the noxious stimuli causing moderate to severe pain.
Provision of nonpharmacologic interventions for neonatal pain is an evidence-based nursing practice that should be initiated by neonatal nurses and parents.
151
A recent survey of NICU nurses found that when rationing of nursing inter­ventions (limiting or omitting interventions to par­ticular patients) occurs, provision of comfort care is “often” and “very often” rationed.
13,102
339
Another survey
CHAPTER 12 Pain and Pain Relief
https://t.me/medicina_free
311
found that 64% of NICU caregivers used nonphar­macologic interventions for heel sticks or venipunc­tures.50 As partners in care, parents should be
encouraged, facilitated, and educated to engage in providing comfort measures for their infants hav­ing painful procedures.68 Nonpharmacologic inter­ventions that have been found to offer the most comfort during a painful intervention include non­nutritive sucking, breastfeeding, skin-to-skin con­tact (kangaroo care) with the mother or another immediate postpartum mother,
285,293
facilitated
tucking, rocking, and holding.* Who better than parents can provide these interventions? Research shows the efficacy of parental involvement.
Initiation of skin-to-skin contact,
168
taste, and suckling was described in full-term infants receiv­ing heel sticks for genetic screens, who experienced less crying (91%) and grimacing (84%) when being held and breastfed by their mothers.
75,167
Numerous studies show that very preterm, healthy preterm, and term newborns (between 28 and 36 weeks’ PMA) who received heel sticks experienced diminished behavioral and physiologic pain response, less crying, and quicker recovery when being held skin-to-skin (e.g., kangaroo care) by their mothers for 15 to 30 minutes before and during the procedure. If
the preterm infant’s mother is not available, does provision of skin-to-skin care by the father or an unrelated woman result in lower pain responses? This question has been researched in two published studies with the following results: (1) fathers were marginally less effective than mothers in decreasing their preterm infant’s pain response,
219
(2) unre­lated females had a small, although not negligible, decrease in their ability to relieve infant pain, and fathers are more acceptable to the baby’s mother than an unrelated female to provide this intimate
216
care.
Animal studies show that the short-term
and long-term effects of repeated pain are ame­liorated by the presence and ministrations of the mother;
413
perhaps the presence of the human
mother or parent provides the same protec­tion for the human neonate.* One study found
concordance between mother and infant cortisol levels during heel lance, which supports the stress
* References 79, 84, 123, 194, 310, 314, 319, 359.
* References 48, 69, 79, 84, 95, 96, 99, 169, 219, 291, 300, 310, 314.
regulatory role of maternal skin-to-skin care during painful procedures.
78
Skin-to-skin care is the most effective nonphar-
macologic intervention for neonatal pain,
193,321
and
barriers to use need to be identified and addressed. One barrier to using skin-to-skin care and breast­feeding to relieve neonatal pain during invasive procedures such as heel stick and injections is the uncomfortable position of the professional per­forming the procedure. An ergonomically sound protocol using an adjustable height stool has been developed and tested in the clinical setting.97 This protocol has resulted in a more comfortable posi­tion for the professional and more use of skin-to­skin care and breastfeeding for neonatal pain relief during the procedure.
97
Developmental care not only prevents pain but also decreases behavioral and physiologic pain scores in preterm infants.
79,365
A recent study of a simple diaper change in VLBW preterm infants showed less physiologic response (e.g., alteration in heart rate, hypoxia, bradycardia, desaturation events) and less pain response (measured with two pain scales) when developmental care was used before and during the procedure.
365
In this study, develop­mental supports such as opportunities for grasping, hand swaddling, decreasing light and noise, NNS, and body support and containment were used.
NONNUTRITIVE SUCKING
NNS (e.g., the infant’s own fingers or hands or a pacifier) soothes by reducing the infant’s level of arousal and duration of cry while promoting the quiet alert state.69 NNS is effective in reducing
pain in preterm infants during heel stick, cir-
cumcision, immunizations, and ROP screening eye examinations.59 The effect of NNS is immediate,
but the effect ceases immediately on cessation of sucking/removal of the pacifier. Combining NNS and sucrose before and during painful procedures provides a synergistic effect on pain relief for both term and preterm neonates.*
ORAL SUCROSE/GLUCOSE AND BREASTFEEDING
Distressed infants who were offered oral sucrose calmed quickly, stayed calm longer, and spent more time in a quiet alert state than did infants offered only a pacifier.55 Sucking soothes, reduces
* References 56, 73, 257, 259, 298, 383, 400.
UNIT TWO Support of the Neonate312
https://t.me/medicina_free
heart and metabolic rates, induces hand-to-mouth behavior, and elevates the pain threshold through opioid and nonopioid systems.55 Oral administra-
tion of sucrose within 2 to 3 minutes before an invasive procedure (e.g., heel stick/venipunc­ture, bladder catheterization, ROP examination, insertion of gavage tube, arterial stick, echocar­diography, casting) has been shown to decrease crying duration, heart rate, facial activity, and EEG changes associated with pain in full-term and preterm infants.* However, in the first ran-
domized clinical trial of 40 preterm and term infants receiving oral sucrose (24%) for peripheral intravenous catheter (PIV) placement, no efficacy in relieving the neonate’s pain during the procedure was seen.
100
Replication of this study is needed
before widespread application of these findings.
In these studies, the amount (0.05 to 2 mL) and concentrations (24% to 50%) of sucrose varied, but even the smallest dose administered once to preterm infants of 26 to 34 weeks of gestation reduced pain behaviors.
379
The small doses of concentrated sucrose solution used to treat neonatal pain have not been shown to cause hyperglycemia in preterm infants.62 The AAP recommends that oral sucrose/ glucose used for pain relief must be ordered and tracked as a medication.
13
When sucrose is paired with developmen-
tal interventions such as rocking, carrying,
101,422
NNS,
422
ing, parental holding,
prone positioning, facilitated tuck-
radiant warmth,
166
89,157
swaddling
sucrose is more effec-
125,128,131
162
or
tive in decreasing behavioral pain responses. Sensorial saturation (massaging the infant’s face, gently talking to the infant, and instilling a sweet solution on the tongue) is effective in newborn pain relief during minor procedures.49 Sensorial
saturation is more effective than oral glucose alone, but use of sensorial saturation without sweet solu­tion is ineffective. A systematic review of sensorial saturation (i.e., oral sucrose, massage, and caregiver’s voice) found that it is more effective in heel stick
procedures in preterm and term infants than oral sucrose/glucose alone.
259
Combining massage and breastfeeding relieves the pain of venipuncture in term and late preterm infants.
425
In healthy full­term neonates, especially males, sensorial saturation reduces pain scores and markers of oxidative stress after heel stick.
* References 55, 212, 234, 285, 286, 329, 357, 383, 403.
317
Two RCTs of the combination of NNS, oral sucrose, and facilitated tucking during heel stick in preterm infants found reduced arousal during the procedure, less crying and fussing, and better sleep than routine care alone.
422
For intrusive procedures, use of a supportive bundle (i.e., modulating the infant’s state, NNS, facilitated tucking, and oral sucrose) increased premature infants’ sleep time and efficiency as well as decreased bouts of awakening after the procedure.
246
In a systematic meta-anal-
ysis of 74 studies of sucrose use for analgesia, sucrose was found to be safe, effective, and cost-effective for single painful procedures (e.g., heel stick/venipuncture/intramuscular [IM] injection) for preterm and term neonates.
addition of liposomal lidocaine to sucrose in one study did not further decrease the pain of venipunc­ture in healthy term newborns.
394
Despite being aware that sucrose relieves pain, only 10% of sur­veyed NICUs used sucrose before a heel stick, and only 11% used sucrose before venipuncture. other surveys found that (1) only 33% of responding NICUs used sucrose before routine painful proce­dures, and (2) NICUs in eight European countries found poor compliance with pain management guidelines for heel stick and other invasive proce-
262
dures.
The use of sucrose for neonatal heel lance increased by 84% after an educational intervention for NICU staff.
359
A systematic review of eight studies for the safety and efficacy of repeated oral sucrose for repeated procedural pain found that (1) different study designs prohibited a meta-analysis; (2) repeated sucrose was effective in decreasing behavioral pain response and composite pain scores; and (3) repeated sucrose had variable efficacy in altering physiologic pain response for preterm (less efficacy in two studies) and term (less variability in one study) infants.
During repeated painful procedures, combining NNS and sucrose provides better pain relief than either intervention used alone,
149
and repeated
use of skin-to-skin care continues to provide pain relief for preterm infants.
150
None of the studies reported adverse outcomes from repeated sucrose use. Neurodevelopmental outcomes were mixed and included: (1) repeated sucrose use for repeated procedural pain would not lead to poor neurologic development (two studies); (2) preterm infants less than 31 weeks’ GA who received more than 10 doses of sucrose/24 hours in the first week of life had poorer neurologic outcomes than infants
379
169
The
Two
148
CHAPTER 12 Pain and Pain Relief
https://t.me/medicina_free
313
receiving fewer doses; and (3) no study reported long-term neurodevelopmental outcomes. There is limited research supporting the safety and effi­cacy of repeated sucrose for repeated procedural pain, and multicenter, prospective, large RCTs are needed.
148
The benefits of sucrose for pain relief have been shown to provide comfort to the infant during subsequent caregiving activities.
393
Two hundred and forty neonates were randomized to a placebo or sucrose-treated group for all nee­dle procedures. After the painful procedure, those infants receiving sucrose reacted to a diaper change with lower pain scores than the infants receiving only a placebo. The comforting benefits of sucrose remained even after the painful procedure was complete.
393
The Academy of Breastfeeding Medicine supports that when available, breastfeeding should be the first choice to alleviate procedural pain in neonates.
52,337
When possible, breastfeed­ing throughout the procedure, rather than pumped breast milk, offers more comfort because of the synergism between skin-to-skin contact with the mother, sucking, and reception of breast milk by the infant.52 An RCT comparing breast milk with sucrose for pain relief in 71 late preterm infants (born at 32 to 37 weeks’ PMA) undergoing heel lance was conducted in the Netherlands.
361
Using the PIPP assessment scale, there was no significant difference in pain scores between the preterm infants receiving breast milk (directly breastfed or bottle-fed) and those receiving sucrose. A random­ized crossover study comparing expressed breast milk and oral sucrose for relief of pain associated with venipuncture found the same analgesic effect in most preterm infants; however, sucrose had bet­ter pain relief in extremely preterm infants.92 An RCT comparing the analgesic effect of sucrose and breastfeeding during venipuncture in healthy 3-day-old newborns found equal pain relief for both methods as measured by NIRS.
338
Salivary cortisol levels from birth to 1 year of age are 40% higher in breastfed infants compared with formula-fed infants.79 The analgesic effect of breast milk may be a result of these higher cortisol levels.70 Concerns about breastfeeding as a com-
fort measure during painful procedures have been raised. To explore these concerns, a study of
57 preterm infants (30 to 36 weeks’ GA) were ran­domized to be breastfed or given a soother during
a blood collection procedure.
200
Preterm infants
with mature breastfeeding skills had lower pain scores during the procedure, all breastfed infants had lower pain scores after the procedure, and use of breastfeeding as a comfort measure did not interfere with the acquisition of breastfeed­ing skills.
200
A more recent study comparing breast milk and sucrose for reducing the pain of ROP examination found that preterm infants receiving 1 mL of breast milk recovered more quickly, and their vital signs returned to baseline more quickly than those preterm infants receiving sucrose.
352
An­other study evaluated the use of breast milk versus swaddling versus oral sucrose to relieve the pain of ETT suctioning and found no difference between them in relieving pain.
118
Breastfeeding for immu­nizations lowers pain scores and heart rates, shortens the duration of crying, and prevents lower oxygen saturations.
130
When compared with skin-to-skin care and swaddling, breastfeeding was more effective than either in reducing pain of immunizations in healthy term neonates.
134
Several studies have compared the use of
glucose versus sucrose for pain relief, with con­flicting results. A comparison of oral glucose versus
sucrose showed that glucose solution (33% to 50%) was more effective in reducing pain response in term newborns having heel sticks.
181
Another study found that 30% sucrose solution was more effective in reducing crying time than 10% to 30% glucose solutions.
211
When (30%) oral glucose solution was given to full-term newborns undergoing venipunc­ture compared with (1) EMLA cream
165
and (2) subcutaneous injections,72 the infants treated with glucose had significantly lower pain scores. Oral
glucose and facilitated tucking by parents was found to be more effective and preferred over the use of opioids in preterm infants receiving heel sticks and pharyngeal suction.
43
A meta-analysis of 38 RCTs found that use of 20% to 30% oral glucose solutions reduced preterm infants’ pain scores and crying with both heel lance and venipuncture,63 but was ineffective for longer procedures such as eye examnations.
103
Another more recent study of the efficacy of oral glucose (25%) versus oral sucrose (24%) use for pain relief during heel lance in 94 preterm neonates in the first 48 hours of life found com­parable pain relief.
238
Various strengths of oral
glucose solutions are effective in relieving neonatal pain: (1) a 25% solution is more effective
UNIT TWO Support of the Neonate314
https://t.me/medicina_free
at relieving pain from an IM injection than NNS
256
alone
; (2) 2 mL of a 10% solution relieves the
pain of venipuncture and nasopharyngeal suc-
270
tioning
; and (3) a 5% solution relieves pain, decreases crying time and heart rate, and increases oxygen saturation in preterm infants receiving IM injections.
399
Efficacy of sweet solutions to relieve neonatal pain has existed since the first trials and reviewers of a recent meta-analysis recommend that placebo/no-treatment trials be abandoned for more ethical control groups.
TACTILE INTERVENTIONS
191
A reassuring human presence (of parents or caregivers) during painful procedures for all neonates in the NICU is mandatory.47 Body con-
tainment of extremities in a flexed position (e.g., holding, swaddling, nesting; providing an oppor­tunity to grasp a finger or pacifier) decreases gross motor movements that contribute to the infant’s increased level of arousal, reduces physiologic and behavioral stress, facilitates energy conservation in the preterm infant, and lowers pain scores.
69,84,395
When swaddling and skin-to-skin care were compared for the relief of pain during veni­puncture in premature infants, pain was relieved equally between the groups when compared with the control group.
122
Premature infants
nested in the prone position experienced lower pain scores and salivary cortisol levels after a heel lance procedure compared with nesting in the supine position.
225
Improper body position­ing contributes to discomfort and pain. An RCT combining five tactile interventions (i.e., swaddling, side/stomach lying, shushing, swinging, and suck­ing) for infant immunizations resulted in less crying time and lower pain scores; these outcomes were greater than those obtained with sucrose alone.
190
Facilitated tucking—gentle containment of flexed extremities in the midline on the trunk while side-lying or supine—during a painful procedure (e.g., heel stick) results in lower heart rate, shorter crying time, less sleep dis­ruption, and fewer sleep-state changes.
102,193,321
One study of facilitated tucking and usual position­ing for heel stick found a “surprising” result: no difference between the two positions in pain inten­sity for the premature infants.
112
Pairing facilitated
tucking with breast milk and NNS effectively reduces pain in premature infants during heel
316
lance.
Several studies of facilitated tucking
during endotracheal tube suctioning have been conducted with the results of lower pain scores in the preterm infants receiving facilitated tuck­ing, when compared with no intervention.
Facilitated tucking (provided by parents for endo­tracheal tube suctioning) showed that participation by parents was a safe, effective pain management strategy that provided parents with an active role in their infant’s pain care and was also preferred by par­ents.42 A more recent study by the same research­ers found lower pain scores with oral glucose
and facilitated tucking by parents during heel stick and pharyngeal suction in very preterm infants.43 Facilitated tucking was perceived pos-
itively by mothers who were either internally motivated to provide it or were externally moti­vated by nurses who suggested their involvement.41 However, two other studies of facilitated tucking and facilitated tucking and oral sucrose89 found that using facilitated tucking alone was less effective in pain management.
Use of a 2-minute massage of the ipsilateral leg before heel stick in preterm infants was safe and resulted in a decreased pain response (decreased pain score and heart rate) compared with nonmas­saged preterm infants.
214
Massage of the arms and hands of infants for 2 minutes before an invasive procedure such as heel stick or other needle stick, including venipuncture, has been shown to reduce pain scores.
84,85
A more recent pilot study of the use of vibration on the lateral aspect of the leg during heel lance resulted in lower N-PASS scores and more stable heart rate during and 2 minutes after the procedure when compared with the con­trol group, without any physiologic or behavioral adverse effects.
274
Motoric boundaries (e.g., containment of extremities) assist a preterm infant to maintain a more secure, controlled response and facilitate self-regulation. Therapeutic interventions include
the use of positions that support flexion and restraint in physiologic position, periodic release of restraint and exercise of extremities, gentle change in body position, and positioning to guard operative sites. Along with comfort mea-
sures, minimizing stimulation in the NICU envi­ronment enables a neonate who is agitated or in pain to use internal and external resources in orga­nizing his or her behavior and develop self-soothing strategies (see Chapter 13). Individualizing care and handling to the infant’s likes and dislikes and listing
7,261
157
CHAPTER 12 Pain and Pain Relief
https://t.me/medicina_free
315
these at the bedside help maintain consistency of care and build trust in these developing neonates.
Picking up, holding, and rocking provide tactile soothing, vestibular stimulation, and the calming effect of rhythmic, repetitive movement. Use of massage, rocking, and water mattresses provides tac­tile, vestibular, and kinesthetic stimuli that modify and accelerate behavioral state control and decrease stress behaviors (see Chapter 13).
AUDITORY INTERVENTIONS
Four small studies of the use of music therapy to relieve the stress and pain of procedures evaluated physiologic and behavioral responses in a total of 75 infants.9 In two studies, intubated preterm infants were exposed to music/no music during routine suctioning. Positive results in the music-exposed
preterm infants included (1) improved oxygen saturation, (2) heart rates between 120 and 160 beats/min for a longer period, (3) more time in sleep state, and (4) quicker recovery time after suctioning.
64,87
Two other studies exposed irritable, agitated, infants in a naturally occurring inconsolable crying episode to music and measured their responses. Again positive results of music ther­apy included (1) improved oxygen saturation, (2) better respiratory and heart rates, (3) state change to drowsy or quiet alert, and (4) fewer crying episodes.
93,229
A more recent study of recorded
maternal voice played during heel lance resulted in significantly lower PIPP scores and less oxy­gen desaturations with no side effects in the group of preterm infants hearing their mothers’ voice, when compared with the control group.86 Playing the same music that mothers listened to while pregnant resulted in less pain response to heel lance in preterm infants.
239
Breastfeeding full-term healthy neonates during a heel lance pro­cedure effectively reduced their pain response, but the addition of music therapy did not enhance pain
423
relief.
Additional data from well-designed studies are required before use of music therapy for preterm infants during painful, stressful conditions can be recommended.
9
Combination of auditory therapies and other nonpharmacologic interventions is more effec­tive than use of single therapies to relieve pain. A randomized study of 62 preterm infants
using a combination of music and touch during painful procedures found similar cortisol concen­trations at birth and at 2 weeks of life between
the experimental and control groups. However, at the beginning of hospitalization and after 2 weeks, beta-endorphin levels were higher and
the PIPP scores lower in the group exposed to the combination of music and touch.
330
Stable
neonates with a PMA of 35 weeks who were exposed to recorded music and sucrose for heel stick procedure were in less pain than when the interventions were administered separately.
354
Preterm infant pain was relieved during veni­puncture with the use of eye covering and playing intrauterine ambient sounds.
COMPLEMENTARY HEALING MODALITIES
6
Complementary healing (e.g., therapeutic touch [TT], acupressure, acupuncture, Reiki) is gaining increasing interest among neonatal health care providers. Little research exists, but clinical reports have depicted the benefits of pain relief with integration of these modalities. A study conducted with registered nurses (RNs) who provided TT to preterm infants (25 to 37 weeks of gestation) revealed that the infants’ responses to TT included (1) decreased heart and respiratory rates; (2) enhanced restful periods; (3) improved sucking, swallowing, and breathing; and (4) a greater ability to interact with the environment.
187
Two more recent studies of the use of TT with a painful procedure have been conducted. In the first study, 10 preterm infants (34 to 40 weeks’ conceptual age) received TT during a low-intensity sensory punctuate stimuli and responded with an increase in cerebral oxygenation.
202
The researchers con-
cluded that TT may have a protective effect
on the autoregulation of cerebral blood flow in the preterm infant during painful stimuli.
202
Another randomized study of the effects of TT before and after procedural pain (heel lance) found no comforting effect for 27 preterm infants less than 30 weeks’ GA.
217
These researchers rec­ommended use of other tactile interventions for pain relief. Reiki uses healing energy to restore balance within the body. Reiki has been used for neonates experiencing neonatal abstinence syndrome without adverse effects and resulted in a slight decrease in heart rate, which may signify relaxation.
331
Acupuncture and acupressure may be safely used to treat pain, agitation, and drug with­drawal in the neonate.
160
A retrospective review
UNIT TWO Support of the Neonate316
https://t.me/medicina_free
of 10 hospitalized infants exposed to acupunc­ture found a decrease in the use of sedatives and analgesics for agitation, successful weaning from ventilators, and transitioning to oral intake after oral aversion without adverse effects.
153
Use of acupuncture in neonates in one NICU decreased the amount of medication needed for agitation and withdrawal, was well tolerated, and was with­out complications.
161
In a small RCT, acupres­sure before heel lance was shown to shorten the procedure and the duration of crying in preterm infants.1 However, in another study, use of nonin­vasive electrical stimulation of acupuncture needles in term infants receiving heel sticks was not shown to be effective in procedural pain relief.
284
Use of noninvasive magnetic acupuncture on the outer ears of newborns (mean gestational age 34 weeks) receiving heel stick procedures resulted in lower pain scores.82 Acupuncture used for 2-week-old to 8-week-old infants with colic resulted in less crying and less colicky crying than standard care by the second week of treatment.
247
More research is needed to validate the use of these modalities for pain management.
153
Activation of cutaneous sensory nerves with a transcutaneous electrical nerve stimulation (TENS) unit and application of thermal topical skin refriger­ant blocks transmission of peripheral pain impulses from procedural pain. Low-frequency, monotonous sounds (e.g., heartbeat, vacuums) quiet the infant and increase behavioral organization. Use of music (see Chapter 13) and recordings of family voices soothe term and preterm infants, resulting in fewer state changes, less time in the arousal state, and increased behavioral organization. However, during circumcision, music (with or without a pacifier) is not an effective distraction or soothing strategy for relief of the pain of the procedure. Another recent study showed that preterm infants presented with
a familiar odor during venipuncture exhibited significantly less crying and grimacing, compared
with the preterm infants presented with an unfa­miliar odor or no odor.
164
However, scents (such as amniotic fluid, breast milk, or maternal odors) presented to premature infants during a heel stick procedure did not reduce neonatal pain scores,
233
yet the odor of mother’s own milk did decrease
pain scores during venipuncture and crying after the procedure.46 Another RCT of preterm infants
exposed to breast milk odor, or recorded maternal
voice or incubator cover during peripheral intra­venous cannulation found that these interventions were simple, safe, and supportive during painful procedures.
5
END-OF-LIFE CARE
When the decision is made to terminate or not begin aggressive medical intervention, the neonate receives end-of-life care, also known as comfort care or palliative care (see Chapter
32). Neonates who receive end-of-life care are at
the threshold of viability, have multiple congenital anomalies that are incompatible with life, or are not responding to NICU interventions (e.g., deteriora­tion in condition despite medical efforts).
End-of-life care should combine comfort
measures, pharmacologic management, devel­opmental care (see Chapter 13), and psychosocial support for the neonate and family (see Chapters 29 and 30).
Parents are acutely aware of (and able to recall) their infant’s suffering, including perceiving the infant’s pain at the end of life.
360
The family is provided a quiet, private, homelike area in which to touch, hold, and interact with their terminally ill neo­nate. Use of skin-to-skin care; soft, soothing music; dimmed lighting; infant massage; holding; and rocking provide both a comforting environment for the infant and family, as well as parenting and comforting opportunities.
83,383
Parents, siblings, and extended family members remain with their infant during and after death. Clergy may be present for family support and may perform a religious service, such as a baptism or blessing.
For comfort care, all invasive procedures, including measurement of vital signs, monitors, machines, and artificial feeding, are discontin­ued. The infant, cleaned and wrapped in a warm
blanket, is held by his or her family. Intravenous access may remain in place for administration of pain medications or sedatives. Medication is
administered in sufficient doses to provide com­fort, relieve pain, and ensure that the infant does not suffer at the end of his or her life.
In the earliest study documenting the use of analgesia for dying infants whose life support was withdrawn or withheld, 165 deaths in a university­based NICU were reviewed.
313
Opioid analgesia
320,336
383
and spiritual
77,80,320,382,383
CHAPTER 12 Pain and Pain Relief
https://t.me/medicina_free
317
was administered to 84% of infants when life sup­port was withdrawn or withheld. Infants with major congenital anomalies (93%) and necrotizing entero­colitis (100%) were more likely to receive opioids than were ELBW infants (66% to 83%). Overall, opioid analgesia was administered to at least 65% of infants. Reasons for life support discontinuation also influenced administration of opioids: (1) futility of treatment (84% medicated), (2) severe lifelong impairment (85% medicated), and (3) suffering caused by treatment (100% medicated). The median dose of opioids was within the usual pharmacologic range in 64% of infants and greater in 36%. Of the infants receiving a higher dose, 94% had previously been receiving an analgesic and may have needed a higher dose as a result of tolerance. The median time until death from the discontinuation of life support was 18 minutes for those who received the standard dose and 20 minutes for those who received the higher dose.
A recent study of end-of-life care found that 85% of infants received analgesic and/or sedative medications before the withdrawal of treatment, 55% at withdrawal and 60% after treatment was terminated.
139
The majority of medication was given by continuous intravenous medications for sedation and pain related to diagnosis. Use of non­pharmacologic interventions for end-of-life care/ pain was minimally documented in this explor­atory, descriptive study. If there is no intravenous access, intranasal fentanyl has also been used in palliative care with dying newborns with no com­plications such as chest rigidity and drug-related apnea. Neonatal restlessness and labored respira­tory efforts were calmed after the intranasal fen­tanyl, with the average time from last dose to death of 61 minutes.
188
A survey of hospital staff providing pediatric palliative care found that 50% of physicians and 30% of nurses reported feeling inexperienced in pain management.99 Providers also shared how personally distressing it is to witness a child’s suffering, especially when pain relief was pos­sible but not available or delivered. In the same
study, families also described their anguish in watch­ing their child experience and suffer any amount of pain and discomfort. Unlike the health care
providers, families thought that everything had been done to alleviate their child’s pain. Another
recent study found that insufficient education in
pain and palliative care of pediatric care providers was a barrier to use of palliative care in children.
113
COMPLICATIONS
A neonate’s complex behavioral response to pain has both short-term and long-term ramifi­cations (Box 12.7).
These behavioral changes may disrupt parent-in­fant interaction and attachment, adaptation to the postnatal environment, feeding behaviors, and growth.
and maldevelopment of sensory systems can occur when distorted or inappropriate sensory input occurs during a critical period in devel­opment. Because of a neonate’s memory, painful experiences increase the infant’s sensitivity to subsequent medical encounters. These initial
experiences may affect the development of attitudes, fears, anxiety, conflicts, wishes, expectations, and patterns of interactions with others.*
term consequences (see Box 12.7) because there is heightened sensitivity at earlier developmen­tal stages. In the most immature preterm infants,
lower pain thresholds and the lack of inhibitory controls influence hypersensitivity.
injury occurs early in development, increased pain sensitivity develops both at the site of the damage (primary hyperalgesia) and in the sur­rounding skin (secondary hyperalgesia) because of hyperinnervation at the site.
pain threshold of the more preterm infant is also influenced by repeated exposures. sequences of this altered excitability include (1) perceiving nonnoxious tactile stimuli as noxious,9 depending on the number of invasive procedures in the previous 24 hours chronic pain and discomfort; (3) associating earlier pain with decreased behavioral responses to pain; (4) variable physiologic responses thresholds, pain tolerance, and higher pain intensity in adolescence.
the importance of infant and family factors (Fig.
12.8) in ameliorating developmental alterations
initiated by early and repeated pain exposures.
* References 19, 21, 33, 61, 62, 139, 179, 183, 184, 271, 303, 321, 327, 337, 346, 373, 391, 394, 397, 406, 419.
29,408
An alteration in brain development
Younger infants are more susceptible to long-
171
When tissue
171,319
The lower
171
The con-
175
; (2) systemic responses of
171
; and (5) lower pain
65,404
Ongoing studies demonstrate
171
UNIT TWO Support of the Neonate318
https://t.me/medicina_free
BOX
12.7
• Less physiologic stability (e.g., alterations in heart and/or respira-
• Less postnatal growth (less weight gain and lower head circumfer-
• Alterations in basal cortisol levels in extremely low gestational age
• Cortisol dysregulation associated with lower IQ in 7-year-old boys
• Alterations in cerebral blood flow,
• Significantly thinner cerebral cortex, predominately in the frontal and
• Inappropriate sensory input (pain) disrupts neural activity, and
• In extremely preterm neonates, disrupts the development of brain
• Hyperinnervation (e.g., neural reorganization in the periphery and
• Altered pain responsiveness:
• Heightened responsiveness to pain (hyperalgesia)/lower pain
• Decreased responsiveness to pain (associated with more expo-
• Reduced tolerance, and lower pain thresholds and higher pain inten-
• Altered behavioral and neurodevelopment
• Temperamental difficulties at 3 months of age
• Altered hypothalamic-pituitary-adrenal (HPA) axis function up to
• Shortening of telomere (region of repetitive nucleotide structure at
* References 19–28,33,62,95,138,139,172–174,179,183,184,271,303,320,327,
345,353,372,389–393,396,405,417,418
Alteration of parent-infant interactions and relationships; temperament and pain expression
LONG-TERM CONSEQUENCES OF REPETITIVE PAIN*
tory rates and blood pressure)
ence) in very preterm infants
preterm infants at 8 and 18 months that suggests a “resetting” of the endocrine stress systems with potential for negative implications for neurodevelopment and later health
born very preterm (but not girls) who have the brain-derived neuro­tropic factor gene variant
tricular hemorrhage and periventricular leukomalacia; altered white matter microstructure
parietal lobes
chronic activation of neuroendocrine system results in abnormal brain development.
regions involved in somatosensory processing (i.e., thalamic volume loss; reduces thalamocortical maturation), which results in poor cog­nitive and motor function at 3 years corrected age.
the spinal cord) associated with increased pain behaviors such as allodynia and hypersensitivity
sity in adolescence (after being born preterm)
school age in children born very preterm, especially in males.
each end of a chromosome) length in very preterm infants that is associated with repeated NICU pain and stress
333,370
threshold
sure to painful experiences) in the NICU and later in infancy and childhood
401,408
81
266
increasing the risk for intraven-
370
126
404
94,163
287
60
327
NICUs with a higher level of infant pain man­agement are associated with better neurobehav­ioral performance (i.e., better attention and arousal,
less lethargy, and better reflexes as measured by the NICU Network Neurobehavioral Scale [NNNS]) in very preterm infants.
286
Studies to evaluate the long-term effects of pharmacologic and comfort interventions are also needed.
61,171,182,183,278,334,408
As mentioned, unanesthetized surgery and/ or unrelieved pain causes suffering that might itself be a risk to life.29 Maintaining metabolic
homeostasis by the appropriate use of anesthetics and analgesics improves postoperative outcome by preventing (1) protein wasting, (2) electrolyte imbalance, (3) impaired immune function, (4) sepsis, (5) metabolic acidosis, (6) pulmonary and cardiac insufficiency, (7) hypermetabolic state, and (8) death.
17,30,120,158
Increasing evidence con-
firms that exposure to prolonged, severe, or untreated pain increases morbidity and alters brain development and subsequent behavioral and physiologic responses to pain.
66,138,172,268,408
13,16,19,20,22,29,
Opioid analgesics may produce respiratory depression severe enough to require mechanical ventilation. Naloxone (0.1 mg/kg IV or IM) is the specific antidote for opioid overdose (see
Table 12.13). Lower doses of naloxone (0.001 to
0.01 mg/kg IV or IM) can be used for moderate respiratory depression. Complete opioid reversal
with 0.1 mg/kg naloxone increases agitation and stress response in neonates with ongoing pain. Subsequently, it is more difficult to manage the neonate’s pain until the effects of the naloxone wear off. Lower doses of naloxone should be used and
the dose titrated to prevent this outcome. An ampule of neonatal naloxone should always be immediately available with the appropriate dose precalculated on the infant’s emergency card. Flumazenil is a specific antagonist for the ben­zodiazepines and should be used to treat respi­ratory depression (see Table 12.13). Respiratory depression may produce hypoxemia, so a pulse oximeter should be standard equipment along with cardiorespiratory monitoring.
13,384
All
equipment for assisted ventilation should be at the bedside.
13
An overdose of local anesthetics can cause seizures, ventricular tachycardia, bradycar­dia, and cardiovascular collapse. Toxic doses for